Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues:    
Product revenues $ 1,538,598 $ 1,922,215
Service and other revenues 84,768 84,857
Total revenues 1,623,366 2,007,072
Cost of revenues 588,967 752,464
Research and development costs 546,328 557,699
Sales and marketing expenses 962,214 1,066,259
General and administrative expenses 952,951 984,270
Operating loss (1,427,094) (1,353,620)
Other income (expense):    
Gain (loss) from change in fair value of derivative liabilities 34,443 (93,046)
Other income (expense), net (794) 4,127
Interest expense, net (247,472) (213,199)
Net loss $ (1,640,917) $ (1,655,738)
Net loss per share attributable to common stockholders:    
Basic and diluted (in dollars per share) $ (0.15) $ (0.46)
Weighted average shares outstanding:    
Basic and diluted (in shares) 10,741,618 3,622,032